Suzhou Iron Technology CO.,LTD. (688329) Fair Value & Analysis
Healthcare · CN · Market cap 1.7B CNY
Fair value as of: Jun 24, 2026
Analysis
Suzhou Iron Technology CO.,LTD. (688329) currently trades at ¥22.61, while our model-based Fair Value estimate is ¥5.38 — implying the stock looks roughly 76.2% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Suzhou Iron Technology CO.,LTD. engages in the provision of intelligent medical material management solutions in China and internationally. The company operates through three segments: Smart Pharmacy, Smart Ward, Smart Warehousing, and Pharmaceutical Information. It offers drug storage and dispensing integration solutions; and automated manipulator dispensing, intelligent storage and retrieval, automated disassembly and repackaging, narcotic drugs dispensary, automated self-service medication dispensing, and automated blister medication dispensing systems, as well as narcotic drugs and category-psychotropic substances management machines. The company also provides intelligent medical supplies management cabinets, self-built building touchless sanitization systems, and hospital-wide integrated nursing solutions, as well as automatic packing machine for tablets and capsules, and integrated machine for medicine basket cleaning and disinfection. In addition, the company offers a softwar…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Suzhou Iron Technology CO.,LTD. (688329) undervalued?
What is the fair value of 688329?
What is the quality score of 688329?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.